Clinical trial
Effect of Omega-3 and Probiotic Dietary Supplements on Elevated High Sensitivity C-reactive Protein (Hs-CRP) as a Marker of Low-grade Inflammation: Targeting Inflammation and Intestinal Barrier Function in the Elderly and Obese
NCT04126330 is registered in ClinicalTrials.gov with Örebro University, Sweden as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Omega-3 and Probiotic Dietary Supplements on Elevated High Sensitivity C-reactive Protein (Hs-CRP) as a Marker of Low-grade Inflammation: Targeting Inflammation and Intestinal Barrier Function in the Elderly and Obese
- Lead sponsor
- Örebro University, Sweden
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 11, 2019
- Completion date
- December 15, 2020
- Enrollment
- 176 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.